These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31132833)

  • 1. Ophthalmologic Manifestation of Inflammatory Bowel Disease: A Review.
    Lee DH; Han JY; Park JJ; Cheon JH; Kim M
    Korean J Gastroenterol; 2019 May; 73(5):269-275. PubMed ID: 31132833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmic manifestations in patients with inflammatory bowel disease: A review.
    Troncoso LL; Biancardi AL; de Moraes HV; Zaltman C
    World J Gastroenterol; 2017 Aug; 23(32):5836-5848. PubMed ID: 28932076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease.
    Soukiasian SH; Foster CS; Raizman MB
    Am J Ophthalmol; 1994 Nov; 118(5):601-11. PubMed ID: 7977573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing IBD outside the gut: ocular manifestations.
    Calvo P; Pablo L
    Dig Dis; 2013; 31(2):229-32. PubMed ID: 24030231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular inflammation in Crohn's disease.
    Salmon JF; Wright JP; Murray AD
    Ophthalmology; 1991 Apr; 98(4):480-4. PubMed ID: 2052301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of ocular involvement in patients with inflammatory bowel disease.
    Yilmaz S; Aydemir E; Maden A; Unsal B
    Int J Colorectal Dis; 2007 Sep; 22(9):1027-30. PubMed ID: 17262200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of episcleritis and scleritis in some Japanese patients.
    Nakajima N; Hayasaka S
    Ophthalmologica; 1995; 209(5):256-9. PubMed ID: 8570148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmological aspects of IBD.
    Manganelli C; Turco S; Balestrazzi E
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():11-3. PubMed ID: 19530506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of patients with episcleritis and scleritis in an Italian tertiary care referral center.
    Berchicci L; Miserocchi E; Di Nicola M; La Spina C; Bandello F; Modorati G
    Eur J Ophthalmol; 2014; 24(3):293-8. PubMed ID: 24242216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
    Cury DB; Moss AC
    Inflamm Bowel Dis; 2010 Aug; 16(8):1393-6. PubMed ID: 19998457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update in the management of extraintestinal manifestations of inflammatory bowel disease.
    Patil SA; Cross RK
    Curr Gastroenterol Rep; 2013 Mar; 15(3):314. PubMed ID: 23371321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular Manifestations of Inflammatory Bowel Disease.
    Shah J; Shah A; Hassman L; Gutierrez A
    Inflamm Bowel Dis; 2021 Oct; 27(11):1832-1838. PubMed ID: 33501989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of ophthalmic manifestations of inflammatory bowel disease and associated treatments.
    Janardhana P; Al-Kadhi S
    Curr Opin Ophthalmol; 2021 Nov; 32(6):549-554. PubMed ID: 34506327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of extraintestinal manifestations in inflammatory bowel disease.
    Lakatos PL; Lakatos L; Kiss LS; Peyrin-Biroulet L; Schoepfer A; Vavricka S
    Digestion; 2012; 86 Suppl 1():28-35. PubMed ID: 23051724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraintestinal manifestations of inflammatory bowel diseases.
    Kethu SR
    J Clin Gastroenterol; 2006 Jul; 40(6):467-75. PubMed ID: 16825927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].
    Lakatos L; Pandur T; Dávid G; Balogh Z; Küronya P; Tollas A; Lakatos PL
    Orv Hetil; 2003 Oct; 144(40):1965-75. PubMed ID: 14626638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease.
    Cloché V; Buisson A; Tréchot F; Batta B; Locatelli A; Favel C; Premy S; Collet-Fenetrier B; Fréling E; Lopez A; Massoure MP; Humbert AL; Hansmannel F; Guéant JL; Bigard MA; Peyrin-Biroulet L; Angioi K
    Dig Liver Dis; 2013 Mar; 45(3):195-9. PubMed ID: 23200464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.